Oruka Therapeutics (ORKA) Depreciation and Depletion (2024 - 2026)
Oruka Therapeutics' (ORKA) quarterly Depreciation and Depletion came in at $43000.0 in Q1 2026, up 168.75% year-on-year from $16000.0 in Q1 2025, and up 53.57% quarter-over-quarter from $28000.0 in Q4 2025.
Oruka Therapeutics (ORKA) Depreciation and Depletion (2024 - 2026) Analysis & Trends
Oruka Therapeutics' Depreciation and Depletion history runs 3 years deep, the most recent figure standing at $43000.0 for Q1 2026.
- On a quarterly basis, Depreciation and Depletion rose 168.75% year-over-year to $43000.0 in Q1 2026; TTM through Mar 2026 was $110000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $83000.0, up 207.41% from the prior year.
- Depreciation and Depletion grew to $43000.0 in Q1 2026 per ORKA's latest filing, from $28000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $43000.0 in Q1 2026 and bottomed at $16000.0 in Q4 2024.
- The 3-year median for Depreciation and Depletion is $19500.0 (2025), against an average of $23666.7.
- Across the five-year window, Depreciation and Depletion soared 75.0% in 2025 and surged 168.75% in 2026, its largest moves.
- Year by year, Depreciation and Depletion stood at $16000.0 in 2024, then surged by 75.0% to $28000.0 in 2025, then jumped by 53.57% to $43000.0 in 2026.
- Per Business Quant, the three latest ORKA Depreciation and Depletion figures stand at $43000.0 (Q1 2026), $28000.0 (Q4 2025), and $20000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.73 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | - |
| 4 | BeOne Medicines | 472.60 Bn | 467.81 Bn | 1.35 Bn | 39.39 Mn |
| 5 | Vertex Pharmaceuticals | 122.34 Bn | 115.09 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.14 Bn | 61.39 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.79 Bn | 62.79 Bn | - | - |
| 8 | Argenx Se | 56.19 Bn | 51.00 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn | - |
| 10 | Oruka Therapeutics | 958.78 Mn | 127.63 Mn | - | 43,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43,000.00 |
| Mar 31, 2026 | 43,000.00 |
| Dec 31, 2025 | 28,000.00 |
| Dec 31, 2025 | 28,000.00 |
| Sep 30, 2025 | 20,000.00 |
| Sep 30, 2025 | 20,000.00 |
| Jun 30, 2025 | 19,000.00 |
| Jun 30, 2025 | 19,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Dec 31, 2024 | 16,000.00 |
| Dec 31, 2024 | 16,000.00 |